Home › Funds › KEYSTONE INVESTORS PTE LTD › GILD
KEYSTONE INVESTORS PTE LTD position in GILD
GILEAD SCIENCES INC · Health Care
KEYSTONE INVESTORS PTE LTD reported holding 75,116 shares of GILD (GILEAD SCIENCES INC) in its Q2 2026 13F filing — a position valued at US$9.5M, representing 0.51% of its reported portfolio and ranking #40 among its reported holdings. KEYSTONE INVESTORS PTE LTD has disclosed GILD holdings in 2 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How KEYSTONE INVESTORS PTE LTD's GILD position evolved
KEYSTONE INVESTORS PTE LTD first disclosed a stake in GILD in Q4 2025 at 207,554 shares (US$25.5M). Across 2 filings, KEYSTONE INVESTORS PTE LTD increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 75,116 shares valued at US$9.5M — a reduction of -132,438 shares quarter over quarter.. Notable position changes include a 64% trim in Q2 2026 (shares rose 18% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 207.55K | $25.48M | New |
| Q2 2026 | 75.12K | $9.49M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About GILD and 13F data
GILD (GILEAD SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in GILD — the largest reported positions include Fidelity Management & Research (FMR) (US$8.45B), Capital World Investors (US$5.18B), Capital World Investors (US$5.18B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding GILD
- Fidelity Management & Research (FMR) 66.87M sh · $8.45B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Capital World Investors 40.99M sh · $5.18B · Q2 2026
- Invesco Ltd 39.82M sh · $5.03B · Q2 2026
- PRICE T ROWE ASSOCIATES INC /MD/ 30.00M sh · $3.79B · Q2 2026
- Dodge & Cox 23.68M sh · $2.99B · Q2 2026
- DODGE & COX 23.68M sh · $2.99B · Q2 2026
More on KEYSTONE INVESTORS PTE LTD
FAQ
How long has KEYSTONE INVESTORS PTE LTD held GILD?
KEYSTONE INVESTORS PTE LTD has disclosed GILD holdings in 2 of the last 3 reported quarters, going back to Q4 2025.
What is KEYSTONE INVESTORS PTE LTD's current position in GILD?
As of Q2 2026, KEYSTONE INVESTORS PTE LTD holds 75.12K shares of GILD (GILEAD SCIENCES INC), valued at $9.49M, representing 0.51% of its reported portfolio and ranking #40.
Has KEYSTONE INVESTORS PTE LTD been buying or selling GILD?
In the latest 13F filing (Q2 2026), KEYSTONE INVESTORS PTE LTD reduced its position in GILD.
Which other funds hold GILD?
Other major institutional holders of GILD include Fidelity Management & Research (FMR), Capital World Investors, Capital World Investors, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.